Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0000899243-22-006413

Acting Chief Business Officer acquired 16,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Savill Corrine Acting Chief Business Officer 2022-02-11 Grant or award +16,500 209,615 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Savill Corrine Acting Chief Business Officer 2022-02-11 Grant or award · Stock Option (Right to Buy) +33,000 33,000 D: show line 2 in the form
Loading xslF345X03/doc4.xml…